These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 15112418)

  • 1. Antiretroviral therapy in resource-poor countries: illusions and realities.
    Desvarieux M; Landman R; Liautaud B; Girard PM
    Am J Public Health; 2005 Jul; 95(7):1117-22. PubMed ID: 15933242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Planning for posttrial access to antiretroviral treatment for research participants in developing countries.
    Shah S; Elmer S; Grady C
    Am J Public Health; 2009 Sep; 99(9):1556-62. PubMed ID: 19608940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-trial access to antiretrovirals: who owes what to whom?
    Millum J
    Bioethics; 2011 Mar; 25(3):145-54. PubMed ID: 19594728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioethical challenges with HIV treatment as prevention.
    Sugarman J
    Clin Infect Dis; 2014 Jul; 59 Suppl 1(Suppl 1):S32-4. PubMed ID: 24926031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing global access to diabetes medicines: policy lessons from the HIV response.
    Teufel F; Bulstra CA; Davies JI; Ali MK
    Lancet Diabetes Endocrinol; 2024 Feb; 12(2):88-90. PubMed ID: 38128554
    [No Abstract]   [Full Text] [Related]  

  • 6. HIV prevention research and global inequality: steps towards improved standards of care.
    Shapiro K; Benatar SR
    J Med Ethics; 2005 Jan; 31(1):39-47. PubMed ID: 15634752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The obligation to provide antiretroviral treatment in HIV prevention trials.
    Lo B; Padian N; Barnes M
    AIDS; 2007 Jun; 21(10):1229-31. PubMed ID: 17545698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Designing an equitable strategy for allocating antiretroviral treatments.
    Capron AM; Reis A
    PLoS Med; 2005 Mar; 2(3):e69. PubMed ID: 15737013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [HIV antiretroviral agents: new threats to accessibility in developing countries].
    Nau JY
    Rev Med Suisse; 2005 Dec; 1(45):2956. PubMed ID: 16425957
    [No Abstract]   [Full Text] [Related]  

  • 10. Standards of care in the antiretroviral rollout world.
    Singh JA
    Lancet; 2004 Sep 11-17; 364(9438):920-2. PubMed ID: 15364176
    [No Abstract]   [Full Text] [Related]  

  • 11. Jewish religious ethics mandate access to antiretroviral drugs in developing countries.
    Spira SC; Wainberg MA
    J Int Assoc Physicians AIDS Care (Chic); 2004; 3(1):7-11. PubMed ID: 15112418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Access to antiretroviral treatment in developing countries: Which financing strategies are possible?
    Beaulière A; Le Maux A; Trehin C; Perez F
    Rev Epidemiol Sante Publique; 2010 Jun; 58(3):171-9. PubMed ID: 20430553
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.